このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Delta Pocc During Spontaneous Breathing Trial to Predict Extubation Failure in Mechanically Ventilated Adults (DELTA-EXT) (DELTA-EXT)

2026年6月22日 更新者:Musso Gabriel Andres、Sanatorio Parque, Argentina

Prospective Observational Single-Center Physiological Study Evaluating Dynamic Stress Estimated by Delta Pocc During a Pressure Support Spontaneous Breathing Trial (PSV 8 cmH2O, PEEP 0 cmH2O) as a Predictor of Extubation Failure in Mechanically Ventilated Adult ICU Patients

This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients.

Liberation from invasive mechanical ventilation is a critical step in ICU care. Although spontaneous breathing trials are routinely used to assess readiness for extubation, some patients may successfully complete the trial despite experiencing excessive respiratory effort and physiological stress, which may increase the risk of extubation failure.

This study will include adult ICU patients who have received invasive mechanical ventilation for at least 24 hours and are considered ready for a spontaneous breathing trial according to the treating clinical team. During the trial, respiratory, ventilatory, and hemodynamic variables will be recorded at predefined time points, including measurements of Delta Pocc as a non-invasive estimate of inspiratory effort and dynamic stress.

The primary outcome is extubation failure within 48 hours after extubation, defined as reintubation and/or the need for rescue non-invasive respiratory support due to post-extubation respiratory deterioration.

The study aims to determine whether this physiological measurement may improve risk stratification during weaning and complement conventional clinical decision-making.

調査の概要

詳細な説明

Background

Liberation from invasive mechanical ventilation requires integration of clinical, hemodynamic, gas exchange, and physiological criteria. The spontaneous breathing trial (SBT) is a standard component of the weaning process and is commonly used to assess readiness for extubation. However, conventional clinical parameters may not fully capture the true respiratory workload experienced by the patient during the trial.

Some patients may tolerate a spontaneous breathing trial according to standard criteria while still developing excessive inspiratory effort and elevated dynamic respiratory stress, potentially predisposing them to post-extubation respiratory failure. Identifying these patients before extubation remains a major clinical challenge.

Delta airway occlusion pressure deflection (Delta Pocc), obtained during a brief expiratory occlusion maneuver, has emerged as a non-invasive physiological surrogate for inspiratory effort and dynamic transpulmonary stress. Incorporating this measurement into routine spontaneous breathing trial assessment may improve identification of patients at increased risk of extubation failure.

Objective

The primary objective of this study is to evaluate the predictive ability of Delta Pocc measured during a standardized spontaneous breathing trial to identify patients at risk of extubation failure within 48 hours.

Secondary objectives include:

To describe the temporal evolution of Delta Pocc and other respiratory physiological variables during the spontaneous breathing trial.

To compare respiratory effort and physiological measurements between patients with successful extubation and those with extubation failure.

To explore the discriminatory performance of Delta Pocc compared with conventional weaning variables.

To evaluate associations between Delta Pocc and clinically relevant outcomes including reintubation, rescue respiratory support, ICU length of stay, hospital length of stay, and mortality.

Study Design

This is a prospective, observational, single-center physiological study conducted in the adult intensive care unit of Sanatorio Parque.

The study does not modify standard clinical management. Participation will not delay extubation decisions or replace the clinical judgment of the treating team.

Study Population

Adult ICU patients receiving invasive mechanical ventilation for at least 24 hours who meet clinical criteria for a spontaneous breathing trial according to routine clinical practice will be eligible.

Inclusion Criteria Age 18 years or older Invasive mechanical ventilation for at least 24 hours Clinical indication for spontaneous breathing trial Hemodynamic and clinical stability Technical feasibility for physiological measurements Exclusion Criteria Significant hemodynamic instability Severe uncontrolled hypoxemia Major arrhythmias Agitation or patient-ventilator asynchrony preventing reliable measurements Significant air leak Technical inability to perform expiratory occlusion maneuver Limitation of life-sustaining treatment Procedures

Baseline respiratory, ventilatory, and hemodynamic variables will be recorded under current ventilatory settings.

A standardized spontaneous breathing trial will then be performed using:

Pressure support ventilation (PSV): 8 cmH2O Positive end-expiratory pressure (PEEP): 0 cmH2O

Measurements will be recorded at:

Baseline 15 minutes 30 minutes

Collected variables include:

Delta Pocc P0.1 Estimated inspiratory muscle pressure Negative inspiratory force Respiratory rate Rapid shallow breathing index Minute ventilation Peak airway pressure Mean airway pressure Oxygen saturation Heart rate Blood pressure Mean arterial pressure Fraction of inspired oxygen

Extubation decisions, preventive non-invasive respiratory support, rescue respiratory support, and reintubation will remain entirely at the discretion of the treating clinical team according to institutional practice.

Outcomes Primary Outcome

Extubation failure within 48 hours after extubation, defined as:

Reintubation, and/or Rescue non-invasive respiratory support due to respiratory deterioration after extubation Secondary Outcomes Spontaneous breathing trial success or failure Cause of spontaneous breathing trial failure Preventive non-invasive respiratory support Reintubation Rescue non-invasive respiratory support Duration of mechanical ventilation ICU length of stay Total hospital length of stay In-hospital mortality Statistical Considerations

The study is designed to evaluate the discriminative performance of Delta Pocc as a predictor of extubation failure.

Receiver operating characteristic (ROC) analysis will be used to assess predictive performance. Repeated physiological measurements will be analyzed using appropriate repeated-measures statistical methods. Multivariable logistic regression may be performed if the number of outcome events is sufficient.

A planned sample size of approximately 110 to 120 patients is expected to provide adequate event capture for exploratory predictive modeling.

Safety

This is a minimal-risk observational study. The only study-specific physiological maneuver is a brief expiratory occlusion measurement performed within standard ventilatory monitoring conditions.

No investigational drugs or devices are involved.

研究の種類

観察的

入学 (推定)

120

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Gabriel A Musso, PT, MSc
  • 電話番号:+54 9 3413068143
  • メール:udikcar@ugr.edu.ar

研究連絡先のバックアップ

  • 名前:Maria C Gomez, PT, MSc
  • 電話番号:+54 9 3415462918
  • メール:cgomez@ugr.edu.ar

研究場所

    • Santa Fe Province
      • Rosario、Santa Fe Province、アルゼンチン、2000
        • Sanatorio Parque
        • コンタクト:
          • Gabriel A Musso, PT, MSc
          • 電話番号:+54 9 3413068143
          • メール:gmusso@ugr.edu.ar
        • コンタクト:
        • 副調査官:
          • Maria C Gomez, PT, MSc
        • 副調査官:
          • Gabriel Appendino, PT, MSc
        • 副調査官:
          • Martin J Managó, PT, MSc
        • 副調査官:
          • Matias Basso, PT, MSc
        • 副調査官:
          • Axel Rubies, PT, MSc
        • 副調査官:
          • Emanuel Giardini, PT, MSc

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

サンプリング方法

非確率サンプル

調査対象母集団

Adult intensive care unit patients receiving invasive mechanical ventilation for at least 24 hours who are considered clinically ready for a spontaneous breathing trial as part of routine weaning assessment.

説明

Inclusion Criteria:

  • Age 18 years or older
  • Invasive mechanical ventilation for at least 24 hours
  • Clinical indication for spontaneous breathing trial according to the treating clinical team
  • Hemodynamic and clinical stability
  • Technical feasibility for respiratory physiological measurements, including expiratory occlusion maneuver

Exclusion Criteria:

  • Significant hemodynamic instability
  • Severe uncontrolled hypoxemia
  • Major cardiac arrhythmias
  • Agitation or patient-ventilator asynchrony preventing reliable measurements
  • Significant air leak interfering with respiratory measurements
  • Technical inability to perform expiratory occlusion maneuver
  • Limitation of life-sustaining treatment
  • Incomplete primary outcome follow-up

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing Trial
Delta airway occlusion pressure deflection will be measured during a standardized spontaneous breathing trial using pressure support ventilation of 8 cmH2O and PEEP of 0 cmH2O. Delta Pocc will be obtained through a brief expiratory occlusion maneuver and analyzed as a non-invasive physiological estimate of inspiratory effort and dynamic respiratory stress. The measurement will not replace clinical judgment or modify standard extubation decisions.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Number of Participants With Extubation Failure Within 48 Hours
時間枠:Within 48 hours after extubation
Number of participants experiencing extubation failure, defined as reintubation and/or the need for rescue non-invasive respiratory support due to respiratory deterioration after extubation.
Within 48 hours after extubation

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Delta Pocc During the Spontaneous Breathing Trial
時間枠:Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Delta airway occlusion pressure deflection (Delta Pocc) measured at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial. The change from baseline and the highest value recorded during the trial will be analyzed.
Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
P0.1 During the Spontaneous Breathing Trial
時間枠:Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Airway occlusion pressure measured 100 milliseconds after the onset of inspiration (P0.1) at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial.
Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial
Number of Participants Requiring Reintubation
時間枠:Within 48 hours after extubation
Number of participants requiring reintubation due to post-extubation respiratory failure.
Within 48 hours after extubation
Number of Participants Requiring Rescue Non-Invasive Respiratory Support
時間枠:Within 48 hours after extubation
Number of participants requiring rescue non-invasive ventilation (NIV) and/or high-flow nasal oxygen therapy (HFNO) because of respiratory deterioration following extubation.
Within 48 hours after extubation
Intensive Care Unit Length of Stay
時間枠:Through ICU discharge, an average of 30 days
Total number of days spent in the intensive care unit from ICU admission until ICU discharge.
Through ICU discharge, an average of 30 days
Number of Participants Who Died During Hospitalization
時間枠:Through hospital discharge, an average of 60 days
Number of participants who died during the index hospitalization.
Through hospital discharge, an average of 60 days

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Gabriel A Musso, PT, MSc、Sanatorio Parque

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年8月1日

一次修了 (推定)

2027年8月1日

研究の完了 (推定)

2027年8月1日

試験登録日

最初に提出

2026年5月27日

QC基準を満たした最初の提出物

2026年6月2日

最初の投稿 (実際)

2026年6月9日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月25日

QC基準を満たした最後の更新が送信されました

2026年6月22日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • SP-DELTAPOCC-EXTFAIL-2026 (その他の識別子:Sanatorio Parque)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data are not planned to be shared because this is a single-center observational study and no formal institutional data-sharing infrastructure is currently in place. De-identified aggregate study results will be reported in scientific publications.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する